Missing Information
  • A System Error Has Occured:0177 - Failed to Load All Sections.
Company:  AXOGEN, INC. (AXGN)
Form Type:  8-K
Filing Date:  5/19/2014 
Last Trade
Last Trade: 
$15.00  
Change: 
-0.05 (-0.33%)  
Trade Time: 
Jun 27  
Market Cap: 
$496.43M
Trade AXGN now with 

© 2017  
Description of Business
We are a global leader in innovative surgical solutions for peripheral nerve injuries. We provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. Our portfolio of products includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments and AviveTM Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed.